Product logins

Find logins to all Clarivate products below.


Spinal Implants – Market Insights – United States

The US spinal implant market will experience steady growth, supported by demographic trends, increased adoption of minimally invasive procedures, robotics and navigation technologies, premium implant innovations, nonfusion technologies, and the ongoing shift of spinal procedures from hospitals to outpatient settings. Competitive dynamics will continue to evolve through technology-driven competition, merger and acquisition, market consolidation, and strategic portfolio realignment.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for spinal implants in the US from 2019 through 2035.

Spinal nonfusion technologies are seeing the fastest growth.

Which product types within spinal nonfusion technologies are growing fastest?

Which commercial coverage trends will affect the market outlook?

Which competitors are gaining share in spinal nonfusion technologies?

How are expanding payer coverage and reimbursement decisions affecting nonfusion adoption?

The gradual shift of spinal implant procedures to outpatient facilities and ASCs impacts the entire spinal implant market.

What regulatory changes are supporting the procedure shift to outpatient and ASC facilities?

How does this migration to the outpatient setting affect procedure ASPs?

What are the advantages of outpatient facilities compared to inpatient facilities?

Which spinal procedures are migrating most rapidly to ASCs and outpatient settings?

IBDs made of titanium, PEEK, or other composite materials are growing in popularity within spinal fusions, prompting manufacturers to expand and strengthen their IBD portfolios.

What approaches are growing in popularity, and at what pace are they growing?

Which IBD innovations are gaining the most success in the US market?

What competitive strategies are manufacturers employing to capture growth in the IBD market?

The use and availability of enabling technologies are increasingly driving the spinal implant market.

How are the main spinal implants manufacturers leveraging their investment into enabling technology and digital innovation to drive implant sales?

What competitive strategies are spinal implant manufacturers making with enabling technology companies to increase the value proposition for spinal implants?

Many manufacturers have broadened their product portfolios by launching new implants or acquiring companies with complementary offerings.

Which competitors are using the breadth of their product portfolios to sustain or increase their spinal implant market shares?

How are competitors expanding their offerings through mergers, acquisitions, and/or partnerships to capture a larger share of the spinal implant market?

Table of contents


Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – United States
The US CRM device market is projected to grow slightly through 2035, driven by the increasing adoption of innovative devices, particularly extravascular ICDs, and CSP-capable pacing and…
Report
Orthopedic Surgical Robotic Devices – Market Insights – Global
The growing adoption of robot-assisted procedures across large-joint replacement and spinal fusion applications, combined with ongoing technological advancements such as real-time 3-D planning,…
Report
Deep Venous Disease Treatment Devices – Market Insights – Global
The uptake of innovative, higher-priced powered thrombectomy devices and their increasing adoption for treating PE—supported by favorable clinical data—will drive strong growth in the global…
Report
Neurovascular Devices – Market Insights – Asia Pacific
The Asia Pacific neurovascular device market will grow moderately through the forecast period, driven by rising procedure volumes, anticipated product launches, and increasing affordability of…
Report
Breast Implants and Reconstructive Devices – Market Insights – United States
The US breast implant and reconstructive device market is projected to advance steadily through 2035, supported by procedure demand but increasingly influenced by safety monitoring and FDA…